Search alternatives:
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
026 decrease » _ decrease (Expand Search), nn decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
60981
Image3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG
Published 2024“…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
-
60982
Table4_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX
Published 2024“…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
-
60983
Table2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX
Published 2024“…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
-
60984
Table3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX
Published 2024“…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
-
60985
Neurogenesis in 12-month-old AβPP-PS1 and wild-type mice on control and specific multi-nutrient diets.
Published 2013“…Post hoc analysis revealed that AβPP-PS1 mice fed the CO diet displayed a significantly decreased relative amount of Dcx+ immature neurons compared to wild-type mice on the CO diet (*<i>p</i> = 0.004). …”
-
60986
Data_Sheet_1_Extramatrical Mycelium and Ectomycorrhizal Community Composition of Quercus pubescens in a Sub-Mediterranean Stress-Prone Environment.PDF
Published 2021“…This was ascribed to a series of stress events that occurred at the site including sequential droughts and wildfire. …”
-
60987
Image2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG
Published 2024“…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
-
60988
DataSheet_1_Dietary Modification for Reproductive Health in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.pdf
Published 2021“…Two reviewers made study selection, data extraction and bias assessment independently. Risk ratios and mean difference with 95% confidence intervals were assessed by a random-effects model. …”
-
60989
Image1_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG
Published 2024“…</p>Results<p>A total of 4,471 cases of oxaliplatin-associated neurological adverse events were identified, with 318 neurological adverse events being documented, among which 87 adverse events satisfied the thresholds of four methodologies. …”
-
60990
DataSheet1_Efficacy and safety of danshen class injections in the treatment of coronary heart disease: a network meta-analysis.docx
Published 2024“…NMA was conducted using RevMan 5.3 and Stata 16.0 software.</p>Results<p>A total of 106 studies including 14,979 patients, involving 10,931 patients, with 5,640 in the experimental group and 5,291 in the control group. …”
-
60991
Supplementary Material for: Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Ana...
Published 2023“…The mALBI grade was classified as 1, 2a, 2b, and 3 in 10 (38.5%), 6 (23.1%), 10 (38.5%), and zero (0.0%) patients, respectively, in the Atez/Bev group and 21 (45.7%), 9 (19.6%), 15 (32.6%), and 1 (2.2%) patient in the LEN group (<i>p</i> = 0.9). …”
-
60992
Model vs. WKY group KEGG pathways (Top 15).
Published 2025“…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
-
60993
Behavioral data.
Published 2025“…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
-
60994
OPLS-DA model parameter.
Published 2025“…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
-
60995
Model vs. SHR group KEGG pathways (Top 15).
Published 2025“…</p><p>Results</p><p>From Day 1–5, compared with the WKY group, both the Model and SHR groups exhibited shortened incubation periods and slower average swimming speeds (<i><i>P</i></i> < 0.01); On day 6, compared with the WKY group, the Model group showed a significant decrease in the number of platform crossings (<i><i>P</i></i> < 0.05), time spent in the target quadrant (<i><i>P</i></i> < 0.05), and total distance traveled in the target quadrant (<i><i>P</i></i> < 0.05). …”
-
60996
Table 1_CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study.docx
Published 2025“…At a median follow-up of 8.5 months, the median PFS and OS were both not reached. …”
-
60997
The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis
Published 2021“…Total periprocedural bleeding was decreased in patients who received TPO-RAs (11.6% vs 15.6%, RR 0.64, 95% CI 0.5–0.9 <i>p</i> = .01. …”
-
60998
Diagnostic criteria for Alcoholic cardiomyopathy.
Published 2025“…</p><p><b>Results:</b> Globally, ACM burden showed significant declines from 1990 to 2021, with age-standardized rates decreasing by 22.5-37.1% across prevalence, mortality and disability measures. …”
-
60999
Results from phylogenetic profile comparison of 635,628 pairs of proteins chosen from among a subset of 1,191 yeast proteins
Published 2011“…The relative performances of all but one (BAE4) reference sets of genomes for yeast are almost the same as that for . A gradual decrease in performance can be noticed as the fraction of eukaryotic genomes in the reference set increases (BAE4, BAE5, BAE6, AE, E), which is counter-intuitive considering the fact that one would hope to see an improved performance on adding more eukaryotic genomes. …”
-
61000
Data_Sheet_2_Role of Downregulation and Phosphorylation of Cofilin in Polarized Growth, MpkA Activation and Stress Response of Aspergillus fumigatus.PDF
Published 2018“…Expression of non-phosphorylated cofilin with a mutation of S5A had little impacts on A. fumigatus, whereas expression of a mimic-phosphorylated cofilin with a mutation of S5E resulted in inhibited growth, increased phospho-MpkA level, and decreased pathogenicity. …”